{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T00:53:15Z","timestamp":1785891195376,"version":"3.56.0"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,2,14]],"date-time":"2022-02-14T00:00:00Z","timestamp":1644796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,2,14]],"date-time":"2022-02-14T00:00:00Z","timestamp":1644796800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004189","name":"Max-Planck-Gesellschaft","doi-asserted-by":"publisher","award":["Max Planck School Matter to Life"],"award-info":[{"award-number":["Max Planck School Matter to Life"]}],"id":[{"id":"10.13039\/501100004189","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","award":["MaxSynBio Consortium"],"award-info":[{"award-number":["MaxSynBio Consortium"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["SFB 1129"],"award-info":[{"award-number":["SFB 1129"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["Gottfried-Wilhelm-Leibniz Program"],"award-info":[{"award-number":["Gottfried-Wilhelm-Leibniz Program"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>SARS-CoV-2 infection is a major global public health concern with incompletely understood pathogenesis. The SARS-CoV-2 spike (S) glycoprotein comprises a highly conserved free fatty acid binding pocket (FABP) with unknown function and evolutionary selection advantage<jats:sup>1,2<\/jats:sup>. Deciphering FABP impact on COVID-19 progression is challenged by the heterogenous nature and large molecular variability of live virus. Here we create synthetic minimal virions (MiniVs) of wild-type and mutant SARS-CoV-2 with precise molecular composition and programmable complexity by bottom-up assembly. MiniV-based systematic assessment of S free fatty acid (FFA) binding reveals that FABP functions as an allosteric regulatory site enabling adaptation of SARS-CoV-2 immunogenicity to inflammation states via binding of pro-inflammatory FFAs. This is achieved by regulation of the S open-to-close equilibrium and the exposure of both, the receptor binding domain (RBD) and the SARS-CoV-2 RGD motif that is responsible for integrin co-receptor engagement. We find that the FDA-approved drugs vitamin K and dexamethasone modulate S-based cell binding in an FABP-like manner. In inflammatory FFA environments, neutralizing immunoglobulins from human convalescent COVID-19 donors lose neutralization activity. Empowered by our MiniV technology, we suggest a conserved mechanism by which SARS-CoV-2 dynamically couples its immunogenicity to the host immune response.<\/jats:p>","DOI":"10.1038\/s41467-022-28446-x","type":"journal-article","created":{"date-parts":[[2022,2,14]],"date-time":"2022-02-14T11:12:29Z","timestamp":1644837149000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["Synthetic virions reveal fatty acid-coupled adaptive immunogenicity of SARS-CoV-2 spike glycoprotein"],"prefix":"10.1038","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8015-3132","authenticated-orcid":false,"given":"Oskar","family":"Staufer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2115-3503","authenticated-orcid":false,"given":"Kapil","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jochen Estebano","family":"Hernandez B\u00fccher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabian","family":"Kohler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Sigl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gunjita","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kate","family":"Vasileiou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Yag\u00fce Relimpio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9184-4959","authenticated-orcid":false,"given":"Meline","family":"Macher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Fabritz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1270-3662","authenticated-orcid":false,"given":"Hendrik","family":"Dietz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0243-1552","authenticated-orcid":false,"given":"Elisabetta Ada","family":"Cavalcanti Adam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1516-9760","authenticated-orcid":false,"given":"Christiane","family":"Schaffitzel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9981-3308","authenticated-orcid":false,"given":"Alessia","family":"Ruggieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilia","family":"Platzman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7518-9045","authenticated-orcid":false,"given":"Imre","family":"Berger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3419-9807","authenticated-orcid":false,"given":"Joachim P.","family":"Spatz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,2,14]]},"reference":[{"key":"28446_CR1","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1126\/science.abd3255","volume":"370","author":"C Toelzer","year":"2020","unstructured":"Toelzer, C. et al. Free fatty acid binding pocket in the locked structure of SARS-CoV-2 spike protein. Science 370, 725\u2013730 (2020).","journal-title":"Science"},{"key":"28446_CR2","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1126\/science.abe1502","volume":"370","author":"S Bangaru","year":"2020","unstructured":"Bangaru, S. et al. Structural analysis of full-length SARS-CoV-2 spike protein from an advanced vaccine candidate. Science 370, 1089\u20131094 (2020).","journal-title":"Science"},{"key":"28446_CR3","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1038\/s41586-020-2179-y","volume":"581","author":"J Shang","year":"2020","unstructured":"Shang, J. et al. Structural basis of receptor recognition by SARS-CoV-2. Nature 581, 221\u2013224 (2020).","journal-title":"Nature"},{"key":"28446_CR4","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1038\/s41586-020-2772-0","volume":"588","author":"DJ Benton","year":"2020","unstructured":"Benton, D. J. et al. Receptor binding and priming of the spike protein of SARS-CoV-2 for membrane fusion. Nature 588, 327\u2013330 (2020).","journal-title":"Nature"},{"key":"28446_CR5","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1016\/j.cell.2020.09.037","volume":"183","author":"L Piccoli","year":"2020","unstructured":"Piccoli, L. et al. Mapping neutralizing and immunodominant sites on the SARS-CoV-2 spike receptor-binding domain by structure-guided high-resolution serology. Cell 183, 1024\u20131042.e1021 (2020).","journal-title":"Cell"},{"key":"28446_CR6","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-71748-7","volume":"10","author":"OC Grant","year":"2020","unstructured":"Grant, O. C., Montgomery, D., Ito, K. & Woods, R. J. Analysis of the SARS-CoV-2 spike protein glycan shield reveals implications for immune recognition. Sci. Rep. 10, 14991 (2020).","journal-title":"Sci. Rep."},{"key":"28446_CR7","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1126\/science.abb2507","volume":"367","author":"D Wrapp","year":"2020","unstructured":"Wrapp, D. et al. Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. Science 367, 1260\u20131263 (2020).","journal-title":"Science"},{"key":"28446_CR8","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.cell.2020.02.058","volume":"181","author":"AC Walls","year":"2020","unstructured":"Walls, A. C. et al. Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein. Cell 181, 281\u2013292.e286 (2020).","journal-title":"Cell"},{"key":"28446_CR9","doi-asserted-by":"publisher","first-page":"eabe5575","DOI":"10.1126\/sciadv.abe5575","volume":"7","author":"C Xu","year":"2021","unstructured":"Xu, C. et al. Conformational dynamics of SARS-CoV-2 trimeric spike glycoprotein in complex with receptor ACE2 revealed by cryo-EM. Sci. Adv. 7, eabe5575 (2021).","journal-title":"Sci. Adv."},{"key":"28446_CR10","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1038\/s41586-020-2665-2","volume":"588","author":"Z Ke","year":"2020","unstructured":"Ke, Z. et al. Structures and distributions of SARS-CoV-2 spike proteins on intact virions. Nature 588, 498\u2013502 (2020).","journal-title":"Nature"},{"key":"28446_CR11","doi-asserted-by":"publisher","unstructured":"Casari, I., Manfredi, M., Metharom, P. & Falasca, M. Dissecting lipid metabolism alterations in SARS-CoV-2. Prog. Lipid Res. https:\/\/doi.org\/10.1016\/j.plipres.2021.101092 (2021).","DOI":"10.1016\/j.plipres.2021.101092"},{"key":"28446_CR12","doi-asserted-by":"publisher","first-page":"73","DOI":"10.3390\/v11010073","volume":"11","author":"B Yan","year":"2019","unstructured":"Yan, B. et al. Characterization of the lipidomic profile of human coronavirus-infected cells: implications for lipid metabolism remodeling upon coronavirus replication. Viruses 11, 73 (2019).","journal-title":"Viruses"},{"key":"28446_CR13","doi-asserted-by":"publisher","unstructured":"Zheng, H. et al. Metabolomics reveals sex-specific metabolic shifts and predicts the duration from positive to negative in non-severe COVID-19 patients during recovery process. Comput. Struct. Biotechnol. J. https:\/\/doi.org\/10.1016\/j.csbj.2021.03.039 (2021).","DOI":"10.1016\/j.csbj.2021.03.039"},{"key":"28446_CR14","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-021-02795-5","volume":"19","author":"S Doaei","year":"2021","unstructured":"Doaei, S. et al. The effect of omega-3 fatty acid supplementation on clinical and biochemical parameters of critically ill patients with COVID-19: a randomized clinical trial. J. Transl. Med. 19, 128 (2021).","journal-title":"J. Transl. Med."},{"key":"28446_CR15","doi-asserted-by":"publisher","unstructured":"Jonsson, S., Mendenhall, M. & Jonsson, C. Case Study Using Nebulized Isomerized Linoleic Acid (LA) for Outpatient Treatment of Symptomatic COVID-19. https:\/\/doi.org\/10.2139\/ssrn.3733231 (SSRN, 2020).","DOI":"10.2139\/ssrn.3733231"},{"key":"28446_CR16","doi-asserted-by":"publisher","first-page":"1782","DOI":"10.1016\/j.ajpath.2020.06.010","volume":"190","author":"BD Hammock","year":"2020","unstructured":"Hammock, B. D., Wang, W., Gilligan, M. M. & Panigrahy, D. Eicosanoids: The overlooked storm in coronavirus disease 2019 (COVID-19)? Am. J. Pathol. 190, 1782\u20131788 (2020).","journal-title":"Am. J. Pathol."},{"key":"28446_CR17","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1038\/s41577-020-0311-8","volume":"20","author":"MZ Tay","year":"2020","unstructured":"Tay, M. Z., Poh, C. M., R\u00e9nia, L., MacAry, P. A. & Ng, L. F. P. The trinity of COVID-19: immunity, inflammation and intervention. Nat. Rev. Immunol. 20, 363\u2013374 (2020).","journal-title":"Nat. Rev. Immunol."},{"key":"28446_CR18","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1002\/eji.201847810","volume":"50","author":"B Kratzer","year":"2020","unstructured":"Kratzer, B., Hofer, S., Zabel, M. & Pickl, W. F. All the small things: how virus-like particles and liposomes modulate allergic immune responses. Eur. J. Immunol. 50, 17\u201332 (2020).","journal-title":"Eur. J. Immunol."},{"key":"28446_CR19","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1038\/s41594-020-00536-8","volume":"27","author":"VS Mandala","year":"2020","unstructured":"Mandala, V. S. et al. Structure and drug binding of the SARS-CoV-2 envelope protein transmembrane domain in lipid bilayers. Nat. Struct. Mol. Biol. 27, 1202\u20131208 (2020).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"28446_CR20","doi-asserted-by":"publisher","unstructured":"Bar-On, Y. M., Flamholz, A., Phillips, R. & Milo, R. SARS-CoV-2 (COVID-19) by the numbers. Elife https:\/\/doi.org\/10.7554\/eLife.57309 (2020).","DOI":"10.7554\/eLife.57309"},{"key":"28446_CR21","doi-asserted-by":"publisher","unstructured":"Abhishek, S. et al. Electroceutical fabric lowers zeta potential and eradicates coronavirus infectivity upon contact. ChemRxiv https:\/\/doi.org\/10.26434\/chemrxiv.12307214.v1 (2020).","DOI":"10.26434\/chemrxiv.12307214.v1"},{"key":"28446_CR22","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1186\/s13046-019-1156-5","volume":"38","author":"Q Zhang","year":"2019","unstructured":"Zhang, Q. et al. ACE2 inhibits breast cancer angiogenesis via suppressing the VEGFa\/VEGFR2\/ERK pathway. J. Exp. Clin. Cancer Res. 38, 173\u2013173 (2019).","journal-title":"J. Exp. Clin. Cancer Res"},{"key":"28446_CR23","doi-asserted-by":"publisher","first-page":"10112","DOI":"10.1128\/JVI.01001-12","volume":"86","author":"M Schneider","year":"2012","unstructured":"Schneider, M. et al. Severe acute respiratory syndrome coronavirus replication is severely impaired by MG132 due to proteasome-independent inhibition of M-calpain. J. Virol. 86, 10112\u201310122 (2012).","journal-title":"J. Virol."},{"key":"28446_CR24","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1016\/j.chom.2020.11.003","volume":"28","author":"M Cortese","year":"2020","unstructured":"Cortese, M. et al. Integrative imaging reveals SARS-CoV-2-induced reshaping of subcellular morphologies. Cell Host Microbe 28, 853\u2013866.e855 (2020).","journal-title":"Cell Host Microbe"},{"key":"28446_CR25","doi-asserted-by":"publisher","unstructured":"Ramanathan, M., Ferguson, I. D., Miao, W. & Khavari, P. A. SARS-CoV-2 B.1.1.7 and B.1.351 spike variants bind human ACE2 with increased affinity. bioRxiv https:\/\/doi.org\/10.1101\/2021.02.22.432359 (2021).","DOI":"10.1101\/2021.02.22.432359"},{"key":"28446_CR26","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/S0022-2275(20)39899-0","volume":"36","author":"GV Richieri","year":"1995","unstructured":"Richieri, G. V. & Kleinfeld, A. M. Unbound free fatty acid levels in human serum. J. Lipid Res. 36, 229\u2013240 (1995).","journal-title":"J. Lipid Res."},{"key":"28446_CR27","doi-asserted-by":"publisher","unstructured":"Archambault, A.-S. et al. Lipid storm within the lungs of severe COVID-19 patients: extensive levels of cyclooxygenase and lipoxygenase-derived inflammatory metabolites. medRxiv https:\/\/doi.org\/10.1101\/2020.12.04.20242115 (2020).","DOI":"10.1101\/2020.12.04.20242115"},{"key":"28446_CR28","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","volume":"181","author":"M Hoffmann","year":"2020","unstructured":"Hoffmann, M. et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell 181, 271\u2013280.e278 (2020).","journal-title":"Cell"},{"key":"28446_CR29","doi-asserted-by":"publisher","unstructured":"Hoffmann, M. et al. Camostat mesylate inhibits SARS-CoV-2 activation by TMPRSS2-related proteases and its metabolite GBPA exerts antiviral activity. EBioMedicine https:\/\/doi.org\/10.1016\/j.ebiom.2021.103255 (2021).","DOI":"10.1016\/j.ebiom.2021.103255"},{"key":"28446_CR30","doi-asserted-by":"publisher","first-page":"3309","DOI":"10.1016\/j.jmb.2020.04.009","volume":"432","author":"JA Jaimes","year":"2020","unstructured":"Jaimes, J. A., Andr\u00e9, N. M., Chappie, J. S., Millet, J. K. & Whittaker, G. R. Phylogenetic analysis and structural modeling of SARS-CoV-2 spike protein reveals an evolutionary distinct and proteolytically sensitive activation loop. J. Mol. Biol. 432, 3309\u20133325 (2020).","journal-title":"J. Mol. Biol."},{"key":"28446_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-21118-2","volume":"12","author":"S Ozono","year":"2021","unstructured":"Ozono, S. et al. SARS-CoV-2 D614G spike mutation increases entry efficiency with enhanced ACE2-binding affinity. Nat. Commun. 12, 848 (2021).","journal-title":"Nat. Commun."},{"key":"28446_CR32","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/s41586-021-03237-4","volume":"591","author":"BA Johnson","year":"2021","unstructured":"Johnson, B. A. et al. Loss of furin cleavage site attenuates SARS-CoV-2 pathogenesis. Nature 591, 293\u2013299 (2021).","journal-title":"Nature"},{"key":"28446_CR33","doi-asserted-by":"publisher","unstructured":"Makowski, L., Olson-Sidford, W. & W-Weisel, J. Biological and clinical consequences of integrin binding via a rogue RGD motif in the SARS CoV-2 spike protein. Viruses https:\/\/doi.org\/10.3390\/v13020146 (2021).","DOI":"10.3390\/v13020146"},{"key":"28446_CR34","doi-asserted-by":"publisher","first-page":"2760","DOI":"10.1128\/JVI.80.6.2760-2770.2006","volume":"80","author":"MS Maginnis","year":"2006","unstructured":"Maginnis, M. S. et al. Beta1 integrin mediates internalization of mammalian reovirus. J. Virol. 80, 2760\u20132770 (2006).","journal-title":"J. Virol."},{"key":"28446_CR35","doi-asserted-by":"crossref","unstructured":"Shoemark, D. K. et al. Molecular simulations suggest vitamins, retinoids and steroids as ligands of the free Fatty acid pocket of the SARS-CoV-2 spike protein**. Angew. Chem. Int. Ed. 60, 7098\u20137110 (2021).","DOI":"10.1002\/anie.202015639"},{"key":"28446_CR36","doi-asserted-by":"publisher","unstructured":"Dofferhoff, A. S. M. et al. Reduced vitamin K status as a potentially modifiable risk factor of severe COVID-19. Clin. Infect. Dis. https:\/\/doi.org\/10.1093\/cid\/ciaa1258 (2020).","DOI":"10.1093\/cid\/ciaa1258"},{"key":"28446_CR37","doi-asserted-by":"crossref","unstructured":"The RECOVERY Collaborative Group. Dexamethasone in hospitalized patients with Covid-19. N. Engl. J. Med. 384, 693\u2013704 (2020).","DOI":"10.1056\/NEJMoa2021436"},{"key":"28446_CR38","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-21767-3","volume":"12","author":"S Zhang","year":"2021","unstructured":"Zhang, S. et al. Bat and pangolin coronavirus spike glycoprotein structures provide insights into SARS-CoV-2 evolution. Nat. Commun. 12, 1607 (2021).","journal-title":"Nat. Commun."},{"key":"28446_CR39","doi-asserted-by":"publisher","first-page":"e13","DOI":"10.1016\/S2666-5247(20)30172-5","volume":"2","author":"M Cevik","year":"2021","unstructured":"Cevik, M. et al. SARS-CoV-2, SARS-CoV, and MERS-CoV viral load dynamics, duration of viral shedding, and infectiousness: a systematic review and meta-analysis. Lancet Microbe 2, e13\u2013e22 (2021).","journal-title":"Lancet Microbe"},{"key":"28446_CR40","doi-asserted-by":"publisher","first-page":"2541","DOI":"10.3390\/v2112541","volume":"2","author":"T Hermesh","year":"2010","unstructured":"Hermesh, T., Moltedo, B., L\u00f3pez, C. B. & Moran, T. M. Buying time-the immune system determinants of the incubation period to respiratory. Viruses. Viruses 2, 2541\u20132558 (2010).","journal-title":"Viruses. Viruses"},{"key":"28446_CR41","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.chom.2020.11.007","volume":"29","author":"AJ Greaney","year":"2021","unstructured":"Greaney, A. J. et al. Complete mapping of mutations to the SARS-CoV-2 spike receptor-binding domain that escape antibody recognition. Cell Host Microbe 29, 44\u201357.e49 (2021).","journal-title":"Cell Host Microbe"},{"key":"28446_CR42","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-19146-5","volume":"11","author":"AG Wrobel","year":"2020","unstructured":"Wrobel, A. G. et al. Antibody-mediated disruption of the SARS-CoV-2 spike glycoprotein. Nat. Commun. 11, 5337 (2020).","journal-title":"Nat. Commun."},{"key":"28446_CR43","doi-asserted-by":"publisher","unstructured":"Atyeo, C. et al. Dissecting strategies to tune the therapeutic potential of SARS-CoV-2-specific monoclonal antibody CR3022. JCI Insight 6, e143129 https:\/\/doi.org\/10.1172\/jci.insight.143129 (2021).","DOI":"10.1172\/jci.insight.143129"},{"key":"28446_CR44","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.chom.2021.02.003","volume":"29","author":"AJ Greaney","year":"2021","unstructured":"Greaney, A. J. et al. Comprehensive mapping of mutations in the SARS-CoV-2 receptor-binding domain that affect recognition by polyclonal human plasma antibodies. Cell Host Microbe 29, 463\u2013476.e466 (2021).","journal-title":"Cell Host Microbe"},{"key":"28446_CR45","unstructured":"Schaffitzel, C. et al. In vitro selection and evolution of protein-ligand interactions by ribosome display. in Protein-Protein Interactions: A Molecular Cloning Manual (ed. Golemis, E. Adams, P.). Ch. 27, (Cold Spring Harbor Laboratory Press, 2005)."},{"key":"28446_CR46","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1172\/JCI13210","volume":"107","author":"AR Brash","year":"2001","unstructured":"Brash, A. R. Arachidonic acid as a bioactive molecule. J. Clin. Invest. 107, 1339\u20131345 (2001).","journal-title":"J. Clin. Invest."},{"key":"28446_CR47","doi-asserted-by":"publisher","unstructured":"Adam, L. et al. Dynamics of SARS-CoV-2 host cell interactions inferred from transcriptome analyses. bioRxiv https:\/\/doi.org\/10.1101\/2021.07.04.450986 (2021).","DOI":"10.1101\/2021.07.04.450986"},{"key":"28446_CR48","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-21665-8","volume":"12","author":"H-X Tan","year":"2021","unstructured":"Tan, H.-X. et al. Immunogenicity of prime-boost protein subunit vaccine strategies against SARS-CoV-2 in mice and macaques. Nat. Commun. 12, 1403 (2021).","journal-title":"Nat. Commun."},{"key":"28446_CR49","doi-asserted-by":"publisher","unstructured":"Pombo, J. P. & Sanyal, S. Perturbation of intracellular cholesterol and fatty acid homeostasis during flavivirus infections. Front. Immunol. https:\/\/doi.org\/10.3389\/fimmu.2018.01276 (2018).","DOI":"10.3389\/fimmu.2018.01276"},{"key":"28446_CR50","doi-asserted-by":"publisher","first-page":"120203","DOI":"10.1016\/j.biomaterials.2020.120203","volume":"264","author":"O Staufer","year":"2021","unstructured":"Staufer, O. et al. Microfluidic production and characterization of biofunctionalized giant unilamellar vesicles for targeted intracellular cargo delivery. Biomaterials 264, 120203 (2021).","journal-title":"Biomaterials"},{"key":"28446_CR51","doi-asserted-by":"publisher","first-page":"eabg6666","DOI":"10.1126\/sciadv.abg6666","volume":"7","author":"O Staufer","year":"2021","unstructured":"Staufer, O. et al. Bottom-up assembly of biomedical relevant fully synthetic extracellular vesicles. Sci. Adv. 7, eabg6666 (2021).","journal-title":"Sci. Adv."},{"key":"28446_CR52","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1038\/nbt1036","volume":"22","author":"I Berger","year":"2004","unstructured":"Berger, I., Fitzgerald, D. J. & Richmond, T. J. Baculovirus expression system for heterologous multiprotein complexes. Nat. Biotechnol. 22, 1583\u20131587 (2004).","journal-title":"Nat. Biotechnol."},{"key":"28446_CR53","doi-asserted-by":"publisher","unstructured":"Frampton, D. et al. Genomic characteristics and clinical effect of the emergent SARS-CoV-2 B.1.1.7 lineage in London, UK: a whole-genome sequencing and hospital-based cohort study. Lancet Infect. Dis. https:\/\/doi.org\/10.1016\/S1473-3099(21)00170-5.","DOI":"10.1016\/S1473-3099(21)00170-5"},{"key":"28446_CR54","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/S0022-1759(99)00149-0","volume":"231","author":"C Schaffitzel","year":"1999","unstructured":"Schaffitzel, C., Hanes, J., Jermutus, L. & Pl\u00fcckthun, A. Ribosome display: an in vitro method for selection and evolution of antibodies from libraries. J. Immunol. Methods 231, 119\u2013135 (1999).","journal-title":"J. Immunol. Methods"},{"key":"28446_CR55","doi-asserted-by":"publisher","first-page":"7346","DOI":"10.1074\/jbc.M007734200","volume":"276","author":"K Els Conrath","year":"2001","unstructured":"Els Conrath, K., Lauwereys, M., Wyns, L. & Muyldermans, S. Camel single-domain antibodies as modular building units in bispecific and bivalent antibody constructs. J. Biol. Chem. 276, 7346\u20137350 (2001).","journal-title":"J. Biol. Chem."},{"key":"28446_CR56","doi-asserted-by":"publisher","unstructured":"Staufer, O., Schroter, M., Platzman, I. & Spatz, J. P. Bottom-up assembly of functional intracellular synthetic organelles by droplet-based microfluidics. Small https:\/\/doi.org\/10.1002\/smll.201906424 (2020).","DOI":"10.1002\/smll.201906424"},{"key":"28446_CR57","doi-asserted-by":"publisher","first-page":"3244","DOI":"10.1021\/acs.nanolett.9b00784","volume":"19","author":"O Staufer","year":"2019","unstructured":"Staufer, O. et al. Adhesion stabilized en masse intracellular electrical recordings from multicellular assemblies. Nano Lett. 19, 3244\u20133255 (2019).","journal-title":"Nano Lett."},{"key":"28446_CR58","doi-asserted-by":"publisher","first-page":"296","DOI":"10.3762\/bjnano.7.27","volume":"7","author":"O Staufer","year":"2016","unstructured":"Staufer, O. et al. Functional fusion of living systems with synthetic electrode interfaces. Beilstein J. Nanotechnol. 7, 296\u2013301 (2016).","journal-title":"Beilstein J. Nanotechnol."},{"key":"28446_CR59","doi-asserted-by":"publisher","unstructured":"Zivanov, J. et al. New tools for automated high-resolution cryo-EM structure determination in RELION-3. Elife https:\/\/doi.org\/10.7554\/eLife.42166 (2018).","DOI":"10.7554\/eLife.42166"},{"key":"28446_CR60","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/nmeth.4193","volume":"14","author":"SQ Zheng","year":"2017","unstructured":"Zheng, S. Q. et al. MotionCor2: anisotropic correction of beam-induced motion for improved cryo-electron microscopy. Nat. Methods 14, 331\u2013332 (2017).","journal-title":"Nat. Methods"},{"key":"28446_CR61","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1006\/jsbi.1996.0013","volume":"116","author":"JR Kremer","year":"1996","unstructured":"Kremer, J. R., Mastronarde, D. N. & McIntosh, J. R. Computer visualization of three-dimensional image data using IMOD. J. Struct. Biol. 116, 71\u201376 (1996).","journal-title":"J. Struct. Biol."},{"key":"28446_CR62","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1016\/S0006-3495(98)74057-3","volume":"75","author":"CA Keller","year":"1998","unstructured":"Keller, C. A. & Kasemo, B. Surface specific kinetics of lipid vesicle adsorption measured with a quartz crystal microbalance. Biophys. J. 75, 1397\u20131402 (1998).","journal-title":"Biophys. J."},{"key":"28446_CR63","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1039\/B918288H","volume":"135","author":"E Briand","year":"2010","unstructured":"Briand, E., Z\u00e4ch, M., Svedhem, S., Kasemo, B. & Petronis, S. Combined QCM-D and EIS study of supported lipid bilayer formation and interaction with pore-forming peptides. Analyst 135, 343\u2013350 (2010).","journal-title":"Analyst"},{"key":"28446_CR64","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-020-00237-9","volume":"5","author":"R Wintjens","year":"2020","unstructured":"Wintjens, R., Bifani, A. M. & Bifani, P. Impact of glycan cloud on the B-cell epitope prediction of SARS-CoV-2 Spike protein. npj Vaccines 5, 81 (2020).","journal-title":"npj Vaccines"},{"key":"28446_CR65","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1016\/j.str.2011.03.010","volume":"19","author":"JA Marsh","year":"2011","unstructured":"Marsh, J. A. & Teichmann, S. A. Relative solvent accessible surface area predicts protein conformational changes upon binding. Structure 19, 859\u2013867 (2011).","journal-title":"Structure"},{"key":"28446_CR66","doi-asserted-by":"publisher","first-page":"W431","DOI":"10.1093\/nar\/gkab314","volume":"49","author":"D Sehnal","year":"2021","unstructured":"Sehnal, D. et al. Mol* Viewer: modern web app for 3D visualization and analysis of large biomolecular structures. Nucleic Acids Res. 49, W431\u2013W437 (2021).","journal-title":"Nucleic Acids Res."},{"key":"28446_CR67","doi-asserted-by":"publisher","first-page":"101017","DOI":"10.1016\/j.plipres.2019.101017","volume":"77","author":"PL Else","year":"2020","unstructured":"Else, P. L. The highly unnatural fatty acid profile of cells in culture. Prog. Lipid Res. 77, 101017 (2020).","journal-title":"Prog. Lipid Res."},{"key":"28446_CR68","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak, K. J. & Schmittgen, T. D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods (San. Diego, Calif.) 25, 402\u2013408 (2001).","journal-title":"Methods (San. Diego, Calif.)"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-28446-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-28446-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-28446-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,24]],"date-time":"2022-11-24T16:11:51Z","timestamp":1669306311000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-28446-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,14]]},"references-count":68,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["28446"],"URL":"https:\/\/doi.org\/10.1038\/s41467-022-28446-x","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,14]]},"assertion":[{"value":"9 July 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"C.B.S. and I.B. declare shareholding in Halo Therapeutics Ltd, related to this Correspondence. Patents describing materials, material compositions and formulations related to the present findings have been filed by O.S., K.G., I.P., J.P.S., C.B.S., and I.B. The remaining authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"868"}}